|
|
|
|
CHROMABOND® Drug II
|
|
special silica phase for SPE of THC and derivatives
acidic analytes from biological fluids (urine, blood ...)
|
|
| Features |
|
base material silica, pore size 60 Å, particle size 45 µm, specific surface 500 m2/g, pH stability 2 – 8
special bifunctional modification - C8 / SB (strong anion exchanger - quaternary amine)
|
|
recommended applications:
extraction of THC and derivatives from urine, blood, serum, plasma (e.g. application 303880)
acidic analytes from biological fluids
|
Ordering information
|
|
Volume
|
Adsorbent weight
|
Pack of |
|
|
CHROMABOND® Drug II polypropylene columns
|
|
|
100 mg |
200 mg
|
500 mg
|
1 g
|
|
|
1 ml
|
730031
|
|
|
|
100 |
|
3 ml
|
|
730413
|
730033
|
|
50 |
|
6 ml
|
|
|
730180
|
730626
|
30 |
|
|
CHROMABOND® LV-Drug II
|
|
|
|
|
500 mg
|
|
|
|
15 ml
|
|
|
732033 |
|
30 |
|
|
CHROMABOND® MULTI 96 Drug II
|
|
|
|
|
|
96 x 100 mg
|
|
|
|
|
|
|
738031.100M
|
1
|
|
|
|
|
|
|
|
|
|
  |
|
|
 |